Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedSummary of changes: added a prominent notice about funding and operating status and updated the revision from v3.1.0 to v3.2.0.SummaryDifference2%
- Check20 days agoChange DetectedMajor change: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization with updated versioning rather than new substantive information in the deleted areas.SummaryDifference0.3%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedUpdated the page to Revision: v3.0.2 and removed the 'Back to Top' element. No other substantive changes to core content are evident.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%
- Check48 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the introduction of terms related to drug safety and pulmonary hypertension. Notably, the revision number has been updated to v3.0.0.SummaryDifference7%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.